Search for other papers by Eun Kyung Jang in
Google Scholar
PubMed
Search for other papers by Dong Eun Song in
Google Scholar
PubMed
Search for other papers by Gyungyub Gong in
Google Scholar
PubMed
Search for other papers by Jung Hwan Baek in
Google Scholar
PubMed
Search for other papers by Yun Mi Choi in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Ji Min Han in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
cytologic findings and a negative histological diagnosis of PTC in the thyroid. They evaluated cytological samples, surgically removed thyroid, and cervical lymph nodes (LNs) twice to scrutinize all samples for missing malignancy or other thyroid pathologies
Search for other papers by Elli Anagnostou in
Google Scholar
PubMed
Search for other papers by Antonios Polymeris in
Google Scholar
PubMed
Search for other papers by Georgios Morphopoulos in
Google Scholar
PubMed
Search for other papers by Alexios Travlos in
Google Scholar
PubMed
Search for other papers by Vassiliki Sarantopoulou in
Google Scholar
PubMed
Search for other papers by Irini Papaspyrou in
Google Scholar
PubMed
the pathology result. The TG level at that point was elevated (132.7 ng/ml, range 3.5-77). Thyrotropin receptor antibodies were within the normal range (<1.58 U/l). During the 4-year follow-up the patient has remained euthyroid. The multinodular
Search for other papers by Sravanthi Nagavalli in
Google Scholar
PubMed
Search for other papers by Marelle Yehuda in
Google Scholar
PubMed
Search for other papers by Laron W. McPhaul in
Google Scholar
PubMed
Search for other papers by Andrew G. Gianoukakis in
Google Scholar
PubMed
Pathology. a Schwannoma, thyroid and parathyroid tissue. b Hypercellular Antoni A pattern of schwannoma. c S-100 stain positive (brown, color in online version only). d Low proliferation index (Ki67). Discussion Primary nonepithelial
Nuclear Medicine, Radiology Department, San Francisco VA Medical Center, San Francisco, Calif., USA
Search for other papers by C. Mari Aparici in
Google Scholar
PubMed
Search for other papers by T. Liu in
Google Scholar
PubMed
node metastasis is very unusual. We report a unique case of papillary thyroid carcinoma with pathology-proven metastasis to an inguinal lymph node. Case Presentation The patient, a 55-year-old man, had an X-ray because of a painful shoulder. The
Search for other papers by Maria Mavromati in
Google Scholar
PubMed
Search for other papers by Essia Saiji in
Google Scholar
PubMed
Search for other papers by Marco Stefano Demarchi in
Google Scholar
PubMed
Search for other papers by Vincent Lenoir in
Google Scholar
PubMed
Search for other papers by Amanda Seipel in
Google Scholar
PubMed
Search for other papers by Paulina Kuczma in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Search for other papers by Minerva Becker in
Google Scholar
PubMed
Search for other papers by Eugenio Fernandez in
Google Scholar
PubMed
Search for other papers by Claudio De Vito in
Google Scholar
PubMed
Search for other papers by Frédéric Triponez in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
surgical procedure performed in most cases and depending on the final pathology and risk of recurrence classification, a second surgery may be necessary to complete total thyroidectomy. Preoperative molecular analyses are now available for suspicious
Search for other papers by José I. López in
Google Scholar
PubMed
Search for other papers by Rosa Zabala in
Google Scholar
PubMed
Search for other papers by José Luís del Cura in
Google Scholar
PubMed
FJ: Role of ultrasound-guided core biopsy in the evaluation of spleen pathology. APMIS 2006;114:492-499. 10.1111/j.1600-0463.2006.apm_378.x 16907854 16 Lopez JI, Fernández de Larrinoa A, Zabala R, Oleada L, del Cura JL, Bilbao FJ: Utilidad de
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Search for other papers by Liliana Ribeiro Santos in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Search for other papers by Inês Vasconcelos Bessa in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Public Health Unit, ACES Baixo Mondego, Coimbra, Portugal
Search for other papers by Adriana Gaspar da Rocha in
Google Scholar
PubMed
Department of Endocrinology, Hospital University Centre of São João, Porto, Portugal
Search for other papers by Celestino Neves in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Selenium in AITD a . Study Year Study type Sample Pathology Main conclusion Zuo et al. ( 16 ) 2021 Systematic review and meta-analysis 17 studies AITD Se-containing supplements greatly reduced the levels of FT3, FT4
INSERM 1086 ANTICIPE, Caen University, Caen, France
Search for other papers by Renaud Ciappuccini in
Google Scholar
PubMed
Search for other papers by Virginie Saguet-Rysanek in
Google Scholar
PubMed
Search for other papers by Marine Dorbeau in
Google Scholar
PubMed
Search for other papers by Justine Lequesne in
Google Scholar
PubMed
Search for other papers by Camille Linard in
Google Scholar
PubMed
Search for other papers by Sophie Lefevre-Arbogast in
Google Scholar
PubMed
Search for other papers by Bénédicte Clarisse in
Google Scholar
PubMed
Search for other papers by Stéphane Bardet in
Google Scholar
PubMed
using Roche Cobas 6000 Tg electrochemiluminescent immunoassays (Roche Diagnostics). The normal reference ranges are 12–22 pmol/L for FT4, 0.27–4.2 mIU/L for TSH, 0–34 IU/mL for TPOAb, and 0–115 IU/mL for TgAb. Pathology All pathological slides
Search for other papers by Nooshin Zargari in
Google Scholar
PubMed
Search for other papers by Maral Mokhtari in
Google Scholar
PubMed
and malignant thyroid lesions. Material and Method During 2012 and 2017, the archive of the Surgical Pathology Department of Shahid Rajaee and Faghihi Hospitals, affiliated to Shiraz University of Medical Sciences, Shiraz, Iran, was searched
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Junyu Tong in
Google Scholar
PubMed
Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
Search for other papers by Maomei Ruan in
Google Scholar
PubMed
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Hao Fu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Qiong Luo in
Google Scholar
PubMed
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Zhiyan Liu in
Google Scholar
PubMed
Search for other papers by Zhongwei Lv in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
Tumors of Endocrine Organs adopted the Turin criteria for PDTC and indicated that any poorly differentiated component should be mentioned in the pathology report. PDTC accounts for 3–5% of all thyroid carcinomas ( 9 , 10 ), and the variation in